Merck KGaA (OTCMKTS:MKGAF) Trading Down 7% – Here’s What Happened

Merck KGaA (OTCMKTS:MKGAFGet Free Report) shares fell 7% on Wednesday . The stock traded as low as $138.6690 and last traded at $138.6690. 116 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 864 shares. The stock had previously closed at $149.11.

Merck KGaA Trading Up 0.8%

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock’s 50 day moving average is $135.62 and its 200-day moving average is $132.54. The company has a market cap of $18.26 billion, a PE ratio of 21.56 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.